Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam on CD4 count and viral load among PLWH on ART: a double-blind randomized controlled clinical trial

This randomized controlled trial investigated whether two medicinal plants, Artemisia annua (sweet wormwood) and Moringa oleifera (drumstick tree), could improve immune function and reduce viral levels in people living with HIV who were already receiving standard antiretroviral therapy (ART). The researchers conducted a double-blind study, meaning neither participants nor researchers knew who received which treatment, to eliminate bias. The study focused on measuring CD4 cell counts, which are crucial immune cells that HIV attacks, and viral load, which indicates how much HIV is present in the blood. Higher CD4 counts and lower viral loads generally indicate better health outcomes for people with HIV. The combination of these traditional medicinal plants with conventional HIV treatment represents an integrative approach to HIV management. Artemisia annua is known for containing artemisinin compounds traditionally used for malaria, while Moringa oleifera contains various bioactive compounds with potential immune-supporting properties. The researchers aimed to determine whether adding these plant-based interventions to standard HIV care could provide additional benefits. This type of research is important because it explores whether traditional medicines might complement modern HIV treatments, potentially offering more affordable or accessible options for HIV management, particularly in resource-limited settings where these plants are readily available.